Varian Medical Systems
The CFO shuffle continues for InVivo Therapeutics | Personnel Moves
InVivo Therapeutics (OTC:NVIV) is on its 3rd financial chief since August, saying it named Steven McAllister to replace interim CFO Gregory Perry.
Perry stepped down effective Dec. 30 to join an unnamed biotechnology company as its CFO, according to a press release.
Varian Medical OKs $6M share buyback for 2014
Palo Alto, Calif.-based Varian Medical (NYSE:VAR) announced today the authorization of a $6 million common stock buyback program, authorized by its board of directors.
Varian Medical slides on missed Q4 earnings, slowing sales growth
Varian Medical (NYSE:VAR) finished fiscal 2013 ahead of Wall Street’s estimates, but investors still shaved nearly 7% from its share price yesterday.
Varian Medical lands FDA clearance for treatment software
Varian Medical (NYSE:VAR) said it won 510(k) clearance from the FDA for its RapidPlan treatment planning software.
Varian sells 20 new radiosurgery systems to U.K. healthcare regulators
The British NHS Supply Chain bought 20 of Varian Medical Systems‘ (NYSE:VAR) TrueBeam devices as part of a planned upgrade of radiotherapy and radiosurgery systems in the nation’s hospitals.
Elekta, Varian settle trade theft, rep-poaching lawsuit
Varian struggles in Japan in Q3, adjusts full-year guidance
Varian Medical Systems (NYSE:VAR) got a little Wall Street love today, despite reporting significant Q3 headwinds that spurred an adjustment of the company’s full-year guidance.
Medicare aims to level reimbursement playing field in fight between Elekta and Varian
Varian slides amid uncertainty in U.S. and E.U. oncology markets
Varian Medical Systems (NYSE:VAR) was none too pleased with the market for its oncology systems, calling its Q2 revenues for that division "disappointing, particularly in the U.S."